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The dermatophytosis treatment in dogs can fail due to dermatophyte resistance to antifungals. The purpose of this study is to determine the 
antifungal sensitivity of dermatophyte Microsporum canis (M. canis) isolated from dogs with dermatophyte. A total of 17 M. canis dog isolates 
were tested for sensitivity to 25 µg fluconazole, 25 µg griseofulvin, 15 µg ketoconazole and 30 µg terbinafine, using the disc diffusion method. 
The M. canis isolates were cultured on Sabouraud's Dextrose Agar media, placed an antifungal disc, and then incubated at 28 C for 7 days. The 
diameter of inhibition zone was measured, then compared with the standard, to determine whether they were sensitive, intermediate or resistant. 
The results of this study indicate that 16 isolates were sensitive to fluconazole; 17 isolates were sensitive to griseofulvin, ketoconazole and 
terbinafine; and one isolate was intermediate to fluconazole. Based on these results, it is concluded that all 17 (100%) isolates are sensitive to the 
antifungals griseofulvin, ketoconazole, terbinafine, and 16 (94%) isolates are sensitive to fluconazole. Thus, the four antifungals can be selected 
to treat dermatophytes in dogs. 
____________________________________________________________________________________________________________________ 




Kegagalan pengobatan dermatofitosis pada anjing dapat terjadi karena resistensi dermatofita terhadap antifungal. Tujuan dari penelitian 
ini adalah mengetahui sifat sensitivitas Microsporum canis (M. canis) isolat anjing terhadap antifungal. Sebanyak 17 M. canis isolat anjing diuji 
sensitivitasnya terhadap 25 μg flukonazol, 25 μg griseofulvin, 15 μg ketoconazol dan 30 μg terbinafine menggunakan metode difusi cakram. 
Isolat M. canis dipupuk pada media Sabourd’s Dextrose Agar, diberikan cakram antifungal, kemudian diinkubasi pada suhu 28° C selama 7 
hari. Zona hambat pertumbuhan koloni M. canis yang dihasilkan diukur diameternya, kemudian dibandingkan dengan standar untuk menentukan 
sensitif, intermedier atau resisten. Hasil penelitian ini menunjukkan sebanyak 16 isolat sensitif terhadap flukonazol, 17 isolat sensitif terhadap 
griseofulvin, ketoconazol dan  terbinafine, serta satu isolat bersifat intermedier terhadap flukonazol. Berdasarkan hasil tersebut disimpulkan 
bahwa semua ke-17 (100%) isolat M. canis isolat anjing sensitif terhadap antifungal griseofulvin, ketoconazol, terbinafine dan 16 (94%) isolat 
sensitif terhadap flukonazol, sehingga keempatnya dapat dipilih sebagai obat dermatofitosis pada anjing. 
____________________________________________________________________________________________________________________ 





Dermatophytosis or ringworm is a skin disease 
(dermatitis) caused by dermatophyte fungi. It often 
affects animals, including dogs and cats, and can be 
transmitted to humans (Moriarty et al., 2012; 
Indarjulianto et al., 2014; Achterman et al., 2015; 
Indarjulianto et al., 2017; Brosh-Nissimov et al., 2018; 
Boehm and Mueller, 2019; Yamada et al., 2019). 
Dermatophytes belong to the class of fungi imperfecti, 
which have three genera: Microsporum, Trichophyton, 
and Epidermophyton. These three genera are zoophilic 
strains and reported dermatophytosis agents in dogs of 
various countries (Bond, 2010; Adimi et al., 2013; 
Indarjulianto et al., 2014; Moriello et al., 2017; 
Yamada et al., 2019; Paryuni et al., 2020). Identified 
dermatophyte species include Microsporum canis (M. 
canis), M. Gypseum, and Trichophyton mentagrophytes, 
with M. canis being the most common dermatophyte 
fungus found in canines. Seker and Dogan (2011) 
reported that 46.0% of ringworm cases on dogs were 
caused by the fungus M. canis, 32.4% were caused by 
T. mentagrophytes, and 10.8% were caused by M. 
gypseum. 
Treatment of dermatophytosis in pets is usually 
done topically and orally, individually or in 
combination. One of the goals of topical therapy is to 
reduce dermatophyte transmission through direct 
contact with infectious substances derived from the 
skin and hair of infected animals. To avoid failure and 
promote fast recovery, the right type and dose of drugs 
must be administered. Proper dermatophytosis 
treatment will also reduce the risk of infection, 
transmission, and zoonotic risks associated with this 
disease, as well as reduce contamination to the 
environment. Some of the drugs used in 
dermatophytosis therapy in dogs and cats include: 
chlorhexidine, enilconazole, fluconazole, Griseofulvin, 
itraconazole (Sporanox), ketoconazole, lufenuron, 
miconazole, and terbinafine (Bond, 2010; Moriello et 
al., 2017).  
Up to 40% of failures to treat M. canis-derived 
dermatophytosis are due to antifungal resistance. In 
recent years, bacterial and fungal resistance to drugs 
has developed, threatening current therapies for 
dermatitis or other infections (Gupta et al., 2009; 
Bueno et al., 2010; Soedarmanto et al., 2011; 
Vandeputte et al., 2012; Aneke et al., 2018; Hsiao et 
al., 2018). M. canis resistance to antifungals can be 
minimized if the drugs administered are sensitive to M. 
canis. Sensitivity to antifungals is  crucial for drug 
selection, as well as for screening the development of 
antifungal resistance (Yenişehirli et al., 2013). 
Therefore, information regarding the sensitivity or 
resistance of M. canis is needed as a basis for selecting 
a dermatophyte treatment. The purpose of this study is 
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to determine the antifungal sensitivity of M. canis 
isolated from dogs. 
 
MATERIALS AND METHODS 
 
The sample used in this study consisted of 17 M. 
canis isolates identified from dogs with dermatitis. 
Other materials used were Sabouraud's dextrose agar 
(SDA, Diagnostic Merck, Germany) and  6-mm 
diameter paper dises each containing 25 μg fluconazole 
(Oxoid, England), 25 μg griseofulvin (Indofarma, 
Indonesia), 15 μg ketoconazole (First Medipharma, 
Indonesia), and 30 μg terbinafine (Interbath, 
Indonesia). The antifungal sensitivity test of M. canis 
was carried out using the disc diffusion method 
(Esteban et al., 2005; Pakshir et al., 2009). M. canis 
isolates were cultured on SDA media and incubated at 
28 C for 7 days (Indarjulianto et al., 2014). The 
colonies that grew on SDA media were mixed with 0.5 
ml of sterile distilled water, and the concentration of 
the suspension was determined using a 
spectrophotometer at 65% transmittance and a 
wavelength of 530 nm. A total of 0.5 ml M. canis 
suspension was spread on the SDA media surface and 4 
antifungal discs were placed on the surface of the 
media, then incubated at 28° C for 7 days. After the 
colonies grew, the zone of growth inhibition around the 
disc was measured and interpreted as sensitive, 
intermediate or resistant based on references from 
Pakshir et al. (2009). 
 
RESULTS AND DISCUSSION 
 
The results of the sensitivity test for 17 M. canis 
isolates against four antifungals can be seen in Table 1 
and Figure 1. Interpretation of the growth inhibition 
zone based on Pakshir et al. (2009) can be seen in 
Table 2. Based on the growth inhibition zone standard, 
all 17 isolates (100%) of M. canis were sensitive to 
griseofulvin, ketoconazole and terbinafine; 16 isolates 
(94.11%) were sensitive and one isolate (5.89%) was 
intermediate to fluconazole. 
Table 1. The results of the sensitivity test of 17 Microsporum canis isolates against antifungals 
Antifungal Concentration 
Zone diameter (mm)* 
Sensitive (%) intermediate (%) Resistant (%) 
Fluconazole 25 µg 16 (94.11%) 1 (5.89%) 0 (0.0%) 
Griseofulvin 25 µg 17 (100%) 0 (0.0%) 0 (0.0%) 
Ketoconazole 15 µg 17 (100%) 0 (0.0%) 0 (0.0%) 
Terbinafine 30 µg 17 (100%) 0 (0.0%) 0 (0.0%) 
* Compared to the standard (Pakshir et al., 2009) 
 
 
Figure 1. Examples of sensitivity test results for Microsporum canis isolates (JA/09) to fluconazole (F), griseofulvin (G), 
ketoconazole (K) and terbinafine (T) 
 
Table 2. Standard results of M. canis sensitivity test to antifungals (sensitive, intermediate and resistant) 
Antifungal Concentration 
Zone diameter (mm)* 
Sensitive Intermediate Resistant 
Fluconazole 25 µg ≥22 21-15 ≤14 
Griseofulvin 25 µg ≥10 - without zone (0) 
Ketoconazole 15 µg ≥30 29-23 ≤22 
Terbinafine 30 µg ≥20 19-12 ≤11 
*Pakshir et al., 2009 
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Sensitivity test by disc diffusion is a good model for 
testing fungal genus as a basis for selecting a suitable 
antifungal. The test can be applied for routine 
laboratory diagnosis and to estimate the resistance of 
dermatophytes to antifungal drugs. Although many 
guidelines such as the National Committee for Clinical 
Laboratory Standards (NCCLS) have published 
sensitivity tests for fungi (M-27A, M-28A), the method 
of evaluating dermatophyte antifungal activity remains 
controversial (Pakshir et al., 2009). Several studies 
have compared the disc diffusion method to the micro-
dilution method. Studies from Karaca and Koç (2004), 
Pakshir et al. (2009), and Nweze et al. (2010), showed 
the disc diffusion method generally compares well to 
the microdilution method. Thus, it can still be used for 
screening. A second method for testing antifungal 
sensitivity, disc diffusion on agar media, is also 
considered simple, easy to use, accurate, inexpensive, 
and requires no special equipment. The disc diffusion 
method has also compared well to liquid dilution 
testing (Fernandes-Torres et al., 2005; Pakshir et al., 
2009; Nweze et al., 2010). 
The results of the sensitivity test corroborate  
findings from Adimi et al. (2013), which determine that 
the potency of griseofulvin, ketoconazole and 
terbinafine are quite high, while fluconazole has less 
potential for M. canis treatment in humans in Tehran, 
Iran. Behnam et al. (2020) reported that among the 
tested antifungals, terbinafine and griseofulvin are the 
most effective agents against M. canis isolates from 
human dermatophyte in Mashhad, Iran. Contrary to the 
results of this study, Abastabar et al. (2019) reported 
that luliconazole, efinaconazole and lanoconazole show 
the highest antifungal activity against M. canis 
dermatophytosis  in human and animal isolates in Iran, 
France and Turkey. This difference may be due to 
variations in the types of antifungals that are often used 
in each country, or the improperuse of antifungals in 
the field. Inaccurate use of antibacterial or antifungal 
can lead to resistance (Vandeputte et al., 2012; Apsari 
and Adiguna, 2013; Indarjulianto et al., 2018; 
Martinez-Rossi et al., 2018). 
Differences or variations in antifungal sensitivity 
results were also reported in dermatophytes other than 
M. canis. Yenişehirli et al. (2013) report that 
griseofulvin is an antifungal drug that is less active 
against T. mentagrophytes isolates. Díaz-Jarabrán et al. 
(2015) found that fluconazole is less active than 
clotrimazole, terbinafine, itraconazole and griseofulvin 
for T. rubrum and T. mentagrophytes. T. 
mentagrophyte isolate was found to be more sensitive 
to itraconazole and ketoconazole than terbinafine 
(Bhatia and Sharma, 2015). According to Singh et al. 
(2019), T. mentagrophytes was the most sensitive to 
ketoconazole and voriconazole, followed by 
itraconazole, amphotericin B, fluconazole, and 
griseofulvin. The high incidence of T. mentagrophytes 
resistance against terbinafine was found in 33 of 41 
samples (65.9%) and griseofulvin in 20 of 41 (48.8%).v 
The resistance characteristic of M. canis to the four 
types of antifungal was not found in this study, but 
there was one isolate that had intermediate properties 
against fluconazole. This result differed from research 
conducted by Anggarini et al. (2015) in humans, which 
found resistance to the dermatophytes griseofulvin, 
ketoconazol, itraconazol, and terbinafine. Although 
only 1 isolate was found to be intermediate, the 
possibility of developing resistance through acquisition 
must be monitored to minimize the risk of resistance. 
Revie et al. (2018) states that antifungal resistance can 
occur through mutations or genomic changes. One way 
to reduce antifungal resistance is to apply antifungal 
treatment in the field using reasonable guidelines. 
According to Apsari and Adiguna (2013), strategies to 
reduce the occurrence of antifungal resistance include 
an antifungal-control program to avoid widespread use 
of antifungals, preventing their improper use and 
dosage. The use of high doses of antifungals, rather 
than low doses, is another strategy for avoiding 
antifungal resistance in less susceptible fungi. The 
absence of antifungal-resistant M. canis isolates 
indicated that all antifungals in this study can be used 




Based on the results of the analysis above, it can be 
concluded that all 17 M. canis isolates from dogs are 
sensitive to griseofulvin, ketoconazole, and terbinafine 
antifungals, and 16 (94%) isolates are sensitive to 
fluconazole. Thus, the four isolates can be selected as 
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